Denis V. Kolibo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Denis V. Kolibo has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Sergiy V. Komisarenko
Department of Molecular Immunology O.V. Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine Kyiv Ukraine
8 shared publications - Svitlana Romaniuk
Department of Molecular Immunology O.V. Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine Kyiv Ukraine
6 shared publications - Andrii A. Kaberniuk
Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York, USA
4 shared publications - Andrii Ju Labyntsev
Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine
4 shared publications - Andrii Siromolot
Department of Technologies of Medical Diagnostics and Treatment, ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, 01033 Kyiv, Ukraine
4 shared publications - Eduard Kavun
Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kiev-30, 252030, Ukraine
3 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in Clinical & Translational Immunology
- Vol. 15 (11)
CRM197 preserves native diphtheria toxin epitopes better than formaldehyde toxoid: structural and serologic implications for vaccines and serodiagnostics
Objectives: To compare the antigenic similarity of cross‐reacting material 197 (CRM197) and formaldehyde‐detoxified diphtheria toxoid (DTx) to native diphtheria toxin (DT), and to assess their suitability for serological monitoring of antitoxin immunity. Methods: Immune sera from vaccinated healthy adult volunteers ( n = 10) and DT‐immunized mice were analysed by ELISA for reactivity against native DT, CRM197, DTx and recombinant non‐toxic DT derivatives, including the A‐fragment, B‐fragment and receptor‐binding domain. Antigenic similarity was quantified using Spearman correlation analysis, and humoral immunogenicity was compared between CRM197 and DTx in murine immunization models. Results: CRM197 showed greater antigenic similarity to native DT than DTx in mice, with Spearman correlation coefficients of 0.844 versus 0.720, respectively. In human sera, reactivity to native DT correlated significantly with reactivity to CRM197 ( ρ = 0.692, P = 0.031), whereas the correlation with DTx did not reach statistical significance ( ρ = 0.523, P = 0.125). CRM197 also induced stronger DT‐reactive antibody responses than DTx in mice. These findings indicate that formaldehyde detoxification may disrupt native epitopes, particularly lysine‐rich regions that may contain protective or diagnostically relevant determinants. Conclusion: CRM197 more faithfully preserves the native antigenic profile of diphtheria toxin than formaldehyde‐detoxified DTx in ELISA‐based serological assays. These results support the evaluation of CRM197 as an improved antigen for monitoring clinical antitoxin immunity and as a structurally faithful platform for next‐generation diphtheria vaccine design.
- 13 November 2026
- Published by Wiley in Clinical & Translational Immunology
- Vol. 15 (11)
Open AccessCRM197 preserves native diphtheria toxin epitopes better than formaldehyde toxoid: structural and serologic implications for vaccines and serodiagnostics
Objectives: To compare the antigenic similarity of cross‐reacting material 197 (CRM197) and formaldehyde‐detoxified diphtheria toxoid (DTx) to native diphtheria toxin (DT), and to assess their suitability for serological monitoring of antitoxin immunity. Methods: Immune sera from vaccinated healthy adult volunteers ( n = 10) and DT‐immunized mice were analysed by ELISA for reactivity against native DT, CRM197, DTx and recombinant non‐toxic DT derivatives, including the A‐fragment, B‐fragment and receptor‐binding domain. Antigenic similarity was quantified using Spearman correlation analysis, and humoral immunogenicity was compared between CRM197 and DTx in murine immunization models. Results: CRM197 showed greater antigenic similarity to native DT than DTx in mice, with Spearman correlation coefficients of 0.844 versus 0.720, respectively. In human sera, reactivity to native DT correlated significantly with reactivity to CRM197 ( ρ = 0.692, P = 0.031), whereas the correlation with DTx did not reach statistical significance ( ρ = 0.523, P = 0.125). CRM197 also induced stronger DT‐reactive antibody responses than DTx in mice. These findings indicate that formaldehyde detoxification may disrupt native epitopes, particularly lysine‐rich regions that may contain protective or diagnostically relevant determinants. Conclusion: CRM197 more faithfully preserves the native antigenic profile of diphtheria toxin than formaldehyde‐detoxified DTx in ELISA‐based serological assays. These results support the evaluation of CRM197 as an improved antigen for monitoring clinical antitoxin immunity and as a structurally faithful platform for next‐generation diphtheria vaccine design.
- Open Access
- 30 October 2026
- Published by Private Company Technology Center in Technology audit and production reserves
- Vol. 5 (4(91)) , 89-99
Digitalization of ecosystem methods of social management and formation of economic security policy in agribusiness
The object of research is the system of economic security of agricultural and agro-industrial enterprises in the context of digitalization and ecosystem management methods. The problem addressed in the research was the fragmentation of scientific approaches to economic security, digitalization and ecosystem management, since existing models of economic security mostly do not take into account digital and ecological variables together. The methodology used is based on comparative and systematizing analysis, morphological assessment and development of an integral indicator called economic security, which combines the economic parameters of agricultural companies within the framework of a reference system for the level of digitalization, trade in agricultural products and conditions for the functioning of ecosystems. It was found that digitalization contributes to increasing the efficiency of land use through better allocation of resources, the spread of technologies and reducing the negative impact on the environment, with the greatest impact on large agribusinesses that use less qualified labor. Agroecological methods create an additional impact on the functioning of ecosystems. Calculations showed that the share of corn in the total volume of grain exports from Ukraine in 2022/23 was 58.8% (27.12 million tons) compared to 37.3% (17.22 million tons) of wheat cargo. Supplementing the base index (Sbase = 0.718) with two components – digital readiness and environmental security (total weight from 0.10 to 0.40), which increases the resulting value of 0.729–0.761 and contributes to the transition of one company from the “Vulnerable” category to the “Safe” category, at least in one of the six analyzed cases. The research results are proposed to be used to improve the system for monitoring economic security, management decisions and state policy regarding the digital and environmental transformation of agribusiness.
- 30 October 2026
- Published by Private Company Technology Center in Technology audit and production reserves
- Vol. 5 (4(91)) , 89-99
Open AccessDigitalization of ecosystem methods of social management and formation of economic security policy in agribusiness
The object of research is the system of economic security of agricultural and agro-industrial enterprises in the context of digitalization and ecosystem management methods. The problem addressed in the research was the fragmentation of scientific approaches to economic security, digitalization and ecosystem management, since existing models of economic security mostly do not take into account digital and ecological variables together. The methodology used is based on comparative and systematizing analysis, morphological assessment and development of an integral indicator called economic security, which combines the economic parameters of agricultural companies within the framework of a reference system for the level of digitalization, trade in agricultural products and conditions for the functioning of ecosystems. It was found that digitalization contributes to increasing the efficiency of land use through better allocation of resources, the spread of technologies and reducing the negative impact on the environment, with the greatest impact on large agribusinesses that use less qualified labor. Agroecological methods create an additional impact on the functioning of ecosystems. Calculations showed that the share of corn in the total volume of grain exports from Ukraine in 2022/23 was 58.8% (27.12 million tons) compared to 37.3% (17.22 million tons) of wheat cargo. Supplementing the base index (Sbase = 0.718) with two components – digital readiness and environmental security (total weight from 0.10 to 0.40), which increases the resulting value of 0.729–0.761 and contributes to the transition of one company from the “Vulnerable” category to the “Safe” category, at least in one of the six analyzed cases. The research results are proposed to be used to improve the system for monitoring economic security, management decisions and state policy regarding the digital and environmental transformation of agribusiness.
- Open Access
- 28 February 2026
- Published by Private Company Technology Center in Technology audit and production reserves
- Vol. 1 (4(87)) , 21-33
Determining the investment attractiveness of the biohacking and bioinnovation market based on market trends in the pharmaceutical business
The object of the study was the process of venture investment in biohacking as a component of the pharmaceutical business, which embodies the development of the specified market. Since research requires significant capital investments, it is worth studying in detail and carefully the issues of financial investments and obtaining income from the specified processes. This work proposes a comprehensive economic analysis of the biohacking industry as a modern investment tool. The consistency of the high growth forecast with the main statistical risks inherent in biotechnology enterprises was described and analyzed. The basis for the hypothesis was the methodology for analyzing the development of the biohacking investment market. The analysis is based on the success rates of clinical trials and the development of FDA medical products from phase I to approval. The results are based on an assessment of the capital market of biotechnology companies in the world after IPOs since 2020. The results confirmed the hypothesis of rapid market growth with a compound annual rate of 19.09% from 2025 to 2034 (forecast). However, there is a rather low overall clinical success rate, about 9.06% between phase I and final drug approval, considering the highest percentage of research outflow between phases II and III (only 31% success). The best value was obtained for rare diseases (about 25.0%), the worst for oncology research (5.1%). The results indicate that most of the investments (about 56%) end in loss. As a result, it was determined that biohacking is currently a high-risk and at the same time highly productive direction, which has a radically different nature of investment. That is why investment should be based on careful, substantiated, reliable data analysis and assessment of the clinical portfolio, considering diversified risks.
- 28 February 2026
- Published by Private Company Technology Center in Technology audit and production reserves
- Vol. 1 (4(87)) , 21-33
Open AccessDetermining the investment attractiveness of the biohacking and bioinnovation market based on market trends in the pharmaceutical business
The object of the study was the process of venture investment in biohacking as a component of the pharmaceutical business, which embodies the development of the specified market. Since research requires significant capital investments, it is worth studying in detail and carefully the issues of financial investments and obtaining income from the specified processes. This work proposes a comprehensive economic analysis of the biohacking industry as a modern investment tool. The consistency of the high growth forecast with the main statistical risks inherent in biotechnology enterprises was described and analyzed. The basis for the hypothesis was the methodology for analyzing the development of the biohacking investment market. The analysis is based on the success rates of clinical trials and the development of FDA medical products from phase I to approval. The results are based on an assessment of the capital market of biotechnology companies in the world after IPOs since 2020. The results confirmed the hypothesis of rapid market growth with a compound annual rate of 19.09% from 2025 to 2034 (forecast). However, there is a rather low overall clinical success rate, about 9.06% between phase I and final drug approval, considering the highest percentage of research outflow between phases II and III (only 31% success). The best value was obtained for rare diseases (about 25.0%), the worst for oncology research (5.1%). The results indicate that most of the investments (about 56%) end in loss. As a result, it was determined that biohacking is currently a high-risk and at the same time highly productive direction, which has a radically different nature of investment. That is why investment should be based on careful, substantiated, reliable data analysis and assessment of the clinical portfolio, considering diversified risks.
- Open Access
- 22 May 2024
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Reports of the National Academy of Sciences of Ukraine
- No. 2,p. 88-99
Характеризація очищеної рекомбінантної субодиниці В дифтерійного токсину як інструмента його дослідження
Очищення препаратів рекомбінантної субодиниці В (SbB) дифтерійного токсину (DT), синтезованої в цитоплазмі, периплазмі і нерозчинних тільцях включення клітин Escherichia coli, проведене за допомогою металоафінної хроматографії після руйнування бактеріальної ДНК та клітинної стінки ензимами, дало можливість позбутися домішок ендогенних пороформуючих протеїнів. Показано, що рекомбінантні похід ні DT, SbB та CRM197 мають однакову спорідненість з рецепторами чутливих та резистентних до токсину клітин ліній Vero і L929 відповідно. Прикладання позитивного потенціалу з боку додавання SbВ (0,3 мкг/мл) до фосфатидилетаноламінвмісної бішарової мембрани у розчині 1 M KCl (pH 4,8) призводить до утворен ня потенціалозалежних іонних каналів з провідністю 20 пСм, як показано у класичних дослідженнях природ ного DT. За даними порівняльного аналізу, характеристики утворення і функціону вання каналів DT найкраще відтворюються SbB, синтезованою в неактивній формі у вигляді тілець включення, та ренатурованою in vitro.
- 22 May 2024
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Reports of the National Academy of Sciences of Ukraine
- No. 2,p. 88-99
Open AccessХарактеризація очищеної рекомбінантної субодиниці В дифтерійного токсину як інструмента його дослідження
Очищення препаратів рекомбінантної субодиниці В (SbB) дифтерійного токсину (DT), синтезованої в цитоплазмі, периплазмі і нерозчинних тільцях включення клітин Escherichia coli, проведене за допомогою металоафінної хроматографії після руйнування бактеріальної ДНК та клітинної стінки ензимами, дало можливість позбутися домішок ендогенних пороформуючих протеїнів. Показано, що рекомбінантні похід ні DT, SbB та CRM197 мають однакову спорідненість з рецепторами чутливих та резистентних до токсину клітин ліній Vero і L929 відповідно. Прикладання позитивного потенціалу з боку додавання SbВ (0,3 мкг/мл) до фосфатидилетаноламінвмісної бішарової мембрани у розчині 1 M KCl (pH 4,8) призводить до утворен ня потенціалозалежних іонних каналів з провідністю 20 пСм, як показано у класичних дослідженнях природ ного DT. За даними порівняльного аналізу, характеристики утворення і функціону вання каналів DT найкраще відтворюються SbB, синтезованою в неактивній формі у вигляді тілець включення, та ренатурованою in vitro.
- Open Access
- 17 August 2022
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 69 (2)
DETECTION OF SPECIFIC ANTIBODIES USING MPT83-MPT63 FUSION PROTEIN IN PATIENTS WITH DESTRUCTIVE PULMONARY TUBERCULOSIS
Introduction. The development of effective test systems for tuberculosis (TB) diagnosis and the study of factors influencing their sensitivity and specificity constitute urgent tasks given the unstable epidemiological situation with TB in Ukraine and the world. The study aimed to determine the clinical and laboratory features of pulmonary TB that may affect the sensitivity of IgG TB antibody detection in human serum by the immuno-enzyme test system “IB-Chem Anti-Mycobacterium tuberculosis”, which was developed at the Palladin Institute of Biochemistry of the NAS of Ukraine and uses recombinant fusion protein MPT83-MPT63 as an antigen. Methods. Sera of 62 patients with chemoresistant pulmonary TB were tested for TB antibodies using an indirect enzyme-linked immunosorbent assay. Dependence of the obtained results on clinical symptoms and signs of pulmonary TB, the frequency of different types of antibiotic resistance, cellular and biochemical parameters of blood were analysed. Results. The sensitivity of the immuno-enzyme test system “IB-Chem Anti-Mycobacterium tuberculosis” for detecting human IgG TB antibodies using recombinant fusion protein MPT83-MPT63 was found to constitute 71.0%; it reached 81.3% in patients with destructive pulmonary TB. Conclusion. The developed test system should primarily be used for the TB diagnosis in patients with destructive changes in the lungs where the diagnostic efficiency of this test system reaches high indicators.
- 17 August 2022
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 69 (2)
Open AccessDETECTION OF SPECIFIC ANTIBODIES USING MPT83-MPT63 FUSION PROTEIN IN PATIENTS WITH DESTRUCTIVE PULMONARY TUBERCULOSIS
Introduction. The development of effective test systems for tuberculosis (TB) diagnosis and the study of factors influencing their sensitivity and specificity constitute urgent tasks given the unstable epidemiological situation with TB in Ukraine and the world. The study aimed to determine the clinical and laboratory features of pulmonary TB that may affect the sensitivity of IgG TB antibody detection in human serum by the immuno-enzyme test system “IB-Chem Anti-Mycobacterium tuberculosis”, which was developed at the Palladin Institute of Biochemistry of the NAS of Ukraine and uses recombinant fusion protein MPT83-MPT63 as an antigen. Methods. Sera of 62 patients with chemoresistant pulmonary TB were tested for TB antibodies using an indirect enzyme-linked immunosorbent assay. Dependence of the obtained results on clinical symptoms and signs of pulmonary TB, the frequency of different types of antibiotic resistance, cellular and biochemical parameters of blood were analysed. Results. The sensitivity of the immuno-enzyme test system “IB-Chem Anti-Mycobacterium tuberculosis” for detecting human IgG TB antibodies using recombinant fusion protein MPT83-MPT63 was found to constitute 71.0%; it reached 81.3% in patients with destructive pulmonary TB. Conclusion. The developed test system should primarily be used for the TB diagnosis in patients with destructive changes in the lungs where the diagnostic efficiency of this test system reaches high indicators.
- 14 February 2022
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Science and innovation
- Vol. 18 (1) , 66-75
РОЗРОБЛЕННЯ ЗАСОБУ ДЛЯ ПОКРАЩЕННЯ КОГНІТИВНИХ ФУНКЦІЙ ТА ЗНИЖЕННЯ РІВНЯ ГОМОЦИСТЕЇНУ
Introduction. Hyperhomocysteinemia is a dangerous metabolic disorder that leads to a number of diseases. Problem Statement. Urgent task is to develop pharmaceutical product for lowering the homocysteine levels without causing side effects. Purpose. To develop the dietary supplement for reducing high homocysteine levels, which has a minimum content of components that may cause side effects; to test the supplement effect on the cognitive abilities of animals and to commercialize the product. Materials and Methods. The developed dietary supplement Alfacognitin contains vitamins B6, B9, B12, C, and choline. For modelling experimental hyperhomocysteinemia in rats, the animals are kept on a diet rich in L-methionine. Blood homocysteine concentrations are determined by the ion exchange liquid column chromatography method with the use of an automatic amino acid analyzer. The behavioral responses and cognitive abilities of the rats have been studied with the use of behavioral tests (open field test, fear conditioning test, and social int e raction test). The production of Alfacognitin dietary supplement has been launched with Nutrimed Ltd. (Kyiv). Results. Alfacognitin has been shown to reduce homocysteine levels, to improve cognitive abilities, social interaction and communication skills, and to compensate functional memory and learning disorders in animals with hyperhomocysteinemia. Specifications for the dietary supplement have been approved, a pilot technology for obtaining the capsule form of the drug has been developed, and an experimental batch has been manufactured. Conclusions. Alfacognitin may reduce the homocysteine levels. Therefore, it may be used to normalize the functional state of the cardiovascular and nervous systems in patients with hyperhomocysteinemia, as well as to improve the cognitive functions, in particular in patients after COVID-19.
- 14 February 2022
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Science and innovation
- Vol. 18 (1) , 66-75
РОЗРОБЛЕННЯ ЗАСОБУ ДЛЯ ПОКРАЩЕННЯ КОГНІТИВНИХ ФУНКЦІЙ ТА ЗНИЖЕННЯ РІВНЯ ГОМОЦИСТЕЇНУ
Introduction. Hyperhomocysteinemia is a dangerous metabolic disorder that leads to a number of diseases. Problem Statement. Urgent task is to develop pharmaceutical product for lowering the homocysteine levels without causing side effects. Purpose. To develop the dietary supplement for reducing high homocysteine levels, which has a minimum content of components that may cause side effects; to test the supplement effect on the cognitive abilities of animals and to commercialize the product. Materials and Methods. The developed dietary supplement Alfacognitin contains vitamins B6, B9, B12, C, and choline. For modelling experimental hyperhomocysteinemia in rats, the animals are kept on a diet rich in L-methionine. Blood homocysteine concentrations are determined by the ion exchange liquid column chromatography method with the use of an automatic amino acid analyzer. The behavioral responses and cognitive abilities of the rats have been studied with the use of behavioral tests (open field test, fear conditioning test, and social int e raction test). The production of Alfacognitin dietary supplement has been launched with Nutrimed Ltd. (Kyiv). Results. Alfacognitin has been shown to reduce homocysteine levels, to improve cognitive abilities, social interaction and communication skills, and to compensate functional memory and learning disorders in animals with hyperhomocysteinemia. Specifications for the dietary supplement have been approved, a pilot technology for obtaining the capsule form of the drug has been developed, and an experimental batch has been manufactured. Conclusions. Alfacognitin may reduce the homocysteine levels. Therefore, it may be used to normalize the functional state of the cardiovascular and nervous systems in patients with hyperhomocysteinemia, as well as to improve the cognitive functions, in particular in patients after COVID-19.
- Open Access
- 31 October 2016
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in The Ukrainian Biochemical Journal
- Vol. 88 (5) , 62-70
Mycobacterium tuberculosis antigens MPT63 and MPT83 increase phagocytic activity of murine peritoneal macrophages
Macrophages (MΦ) are the most described and characterized target and host of mycobacteria. Like other cells of innate immunity MΦ have a wide range of receptor molecules which interact with different pathogen associated molecular patterns (PAMPs). Immunodominant proteins MPT63 and MPT83 that are synthesized in abundance by Mycobacterium bovis or Mycobacterium tuberculosis strains could be involved in development of tuberculosis infection. The aim of this study was to search for effects of these mycobacterial antigens on target cells. For this aim full-sized sequences of MPT83 (rMPT83full) and MPT63 antigens were cloned into plasmid pET24a(+). The increase of phagocytic activity of murine peritoneal macrophages was demonstrated, but not of macrophage-like cells from J774 cell line, which were treated by rMPT63 and rMPT83full proteins for 24 h. This effect of such antigens can be considered as a way to facilitate the consumption of mycobacterial cells by macrophages to avoid other effector mechanisms of innate and adaptive immunity.
- 31 October 2016
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in The Ukrainian Biochemical Journal
- Vol. 88 (5) , 62-70
Open AccessMycobacterium tuberculosis antigens MPT63 and MPT83 increase phagocytic activity of murine peritoneal macrophages
Macrophages (MΦ) are the most described and characterized target and host of mycobacteria. Like other cells of innate immunity MΦ have a wide range of receptor molecules which interact with different pathogen associated molecular patterns (PAMPs). Immunodominant proteins MPT63 and MPT83 that are synthesized in abundance by Mycobacterium bovis or Mycobacterium tuberculosis strains could be involved in development of tuberculosis infection. The aim of this study was to search for effects of these mycobacterial antigens on target cells. For this aim full-sized sequences of MPT83 (rMPT83full) and MPT63 antigens were cloned into plasmid pET24a(+). The increase of phagocytic activity of murine peritoneal macrophages was demonstrated, but not of macrophage-like cells from J774 cell line, which were treated by rMPT63 and rMPT83full proteins for 24 h. This effect of such antigens can be considered as a way to facilitate the consumption of mycobacterial cells by macrophages to avoid other effector mechanisms of innate and adaptive immunity.
- 31 July 2012
- Published by University of South Bohemia in Ceske Budejovice in Journal of Applied Biomedicine
- Vol. 10 (4) , 169-176
Expression of Mycobacterium tuberculosis proteins MPT63 and MPT83 as a fusion: purification, refolding and immunological characterization
Proteins MPT63 and MPT83 which are common for both Mycobacterium tuberculosis and Mycobacterium bovis, due to their high immunogenicity, are thought to play a promising role in the development of immunodiagnostic reagents and vaccines. To enha...
- 31 July 2012
- Published by University of South Bohemia in Ceske Budejovice in Journal of Applied Biomedicine
- Vol. 10 (4) , 169-176
Expression of Mycobacterium tuberculosis proteins MPT63 and MPT83 as a fusion: purification, refolding and immunological characterization
Proteins MPT63 and MPT83 which are common for both Mycobacterium tuberculosis and Mycobacterium bovis, due to their high immunogenicity, are thought to play a promising role in the development of immunodiagnostic reagents and vaccines. To enha...